Member Info for Shareseeker10

25 year revenue of just under $1bn...........

Agreed AVCT & DDDD have many blockbuster projects, check out ORPH too for a more steady investment.

Check out KAT O & W

Anyone who listened to tonight’s webcast will not be selling anytime soon FACT, most traders were flushed out and spooked today on the 10% drop, the mm’s job is to make market action, the only way they’ll do that is by a big jump in the sp.....simples.....

This is massively undervalued, its only a matter of time before we see a big re-rate. Nice buying today.

Please can someone send the link ?

That’s a different pack, much more info on webcast

I’m listening, unbelievable potential !!!!!

Definitely end up blue, same pattern daily, strong afternoons

Terrible move, ride your winners, they aren’t buses !

Future value in billions potentially with news flow very soon.

Revenue is from past

Ok cheers

Would this be another placing ?

All they are doing is “defining a project to start”

Miles away

Do we have potential from the Mondera Vaccine ??????

Cheers guys

Thinking of here & KAT, this is at 52 wk high, what’s the upcoming news flow please ?

Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this VIDEO charting update. Here is our small-cap pharmaceutical special.

Avacta Group (AVCT)
4d Pharma (DDDD)
Genedrive (GDR)
Hemogenyx Pharmaceuticals (HEMO)
Motif Bio (MTFB)
Novacyt SA (NCYT)
Omega Diagnostics Group (ODX)
Open Orphan (ORPH)
Synairgen (SNG)
Tiziana Life Sciences (TILS)
ValiRx (VAL)

https://twitter.com/Share_Talk/status/1257700402339905536

https://www.share-talk.com/share-talk-bulletin-board-heroes-pharma-special-tuesday-5th-may-2020/

Not sure that’s good etiquette, contact him on Twitter

Zak see’s massive upside without the mention of news, on news then boom...

This is in a rock solid bull run which will dip every now and again but is always met by strong buying so never dips more than 10%, the question is;

Do you want to be in or out when we have potentially the biggest RNS AIM has seen in years,CEO said “2 or 3 weeks away” two weeks ago.......

Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this VIDEO charting update.

Avacta Group (AVCT)
4d Pharma (DDDD)
Genedrive (GDR)
Hemogenyx Pharmaceuticals (HEMO)
Motif Bio (MTFB)
Novacyt SA (NCYT)
Omega Diagnostics Group (ODX)
Open Orphan (ORPH)
Synairgen (SNG)
Tiziana Life Sciences (TILS)
ValiRx (VAL)

https://twitter.com/Share_Talk/status/1257700402339905536

https://www.share-talk.com/share-talk-bulletin-board-heroes-pharma-special-tuesday-5th-may-2020/